Trader consensus favoring no new coronavirus pandemic in 2026 rests on sustained low-level SARS-CoV-2 circulation, with CDC data showing COVID-19 emergency department visits at just 0.3% and an Rt of 1.08 as of mid-August 2026. Omicron subvariants such as NB.1.8.1, XFG, and BA.3.2 dominate sequences but produce mild, seasonal illness patterns consistent with endemic equilibrium rather than exponential growth. Population-level immunity from prior infections and vaccinations has narrowed the window for novel sarbecovirus emergence, while global surveillance from WHO and CDC reports no thresholds for pandemic classification. A realistic shift could occur only if a substantially more transmissible or virulent strain evades existing immunity and drives sustained case surges meeting official pandemic criteria before year-end.